1 completed, 1 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Laerdal Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest Double sequential defibirllation, Standard defibrillation - Out of Hospital Cardiac Arrest, Ventricular Fibrillation | Phase 2 / Phase 3 | Recruiting | Gabriel Riva | 916 | 2025-09-08 | 2026-02-17 |
| Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial Fibrinogen Concentrate, Isotonic Saline - Postpartum Haemorrhage | Phase 2 / Phase 3 | Completed | Copenhagen University Hospital at Herlev | 249 | 2011-05-01 | 2013-09-20 |
Death, Sudden (1) · Out-of-Hospital Cardiac Arrest (1) · Postpartum Hemorrhage (1) · Ventricular Fibrillation (1)
Fibrinogen (1) · Sodium Chloride (1)
Denmark (1) · Netherlands (1) · Spain (1) · Sweden (1)
Akil Awad, M.D. Ph.D. (1) · Andreas Claesson, R.N. Ph.D. (1) · Anne J. Wikkelsoe, MD (1) · Arash Afshari, MD (1) · Carl Magnusson, R.N., Ph.D. (1) · Gabriel Riva, M.D. Ph.D. (1) · Hellen McKinnon Edwards, M.D. (1) · Jakob Stensballe, MD, PhD (1) · Jens Langhoff-Roos, MD, DmSc (1) · Johan Israelsson, R.N. Ph.D. (1)
PMID 22805300, PMID 25586727, PMID 42379878
2009 (1)